iTonic

iTonic

Health Care Technology
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

$29.1M

Market Cap • 10/2/2026

2022

(4 years)

Founded

2024

(2 years ago)

IPO

NASDAQ

Listing Exchange

Flag of China

China

Country

Valuation

P/B

1,2

P/S

52,4

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,2

EPS

—

Market Cap

Market Cap

29,1M

EV

28,3M

EV/Revenue

50,8

EV/EBITDA

-3,5

EV/EBIT

-3,5

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-69,2%

Total Yield

-69,2%

Payout

0%

Retained Earnings

-11,4M

Profitability

Gross Margin

60,9%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

178,2%

Capex/Revenue

0,6%

Capex/D&A

2,2%

Capex/OCF

-0,3%

SBC/OCF

—

% PPE

0,5%

% Goodwill

3,7%

ROE

—

ROIC

—

Leverage

N.D./EBITDA

0,2

Debt/Equity

0%

Current Ratio

17,4

Quick Ratio

2

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium